A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors
Year: 2025
Type: article
Language: en
Topic: Peptidase Inhibition and Analysis
Authors and affiliations:
raw_author_name: David Gill
raw_affiliation_strings: Intermountain Health, Salt Lake City, UT, United States
raw_author_name: Charles L. Cowey
raw_affiliation_strings: Baylor Charles A. Sammons Cancer Center, Texas Oncology, Dallas, TX, United States
raw_author_name: Gregory A. Daniels
raw_affiliation_strings: Department of Medicine, Division of Hematology Oncology, University of California San Diego, La Jolla, CA, United States
raw_author_name: David Sommerhalder
raw_affiliation_strings: NEXT Oncology, San Antonio, TX, United States
raw_author_name: Raghad Abdul-Karim
raw_affiliation_strings: Nova Oncology, McAllen, TX, United States
raw_author_name: John M. Kirkwood
raw_affiliation_strings: Medicine, UPMC Hillman Cancer Center and the University of Pittsburgh, Pittsburgh, PA, United States
raw_author_name: Joanna Kolodney
raw_affiliation_strings: Medical Oncology, West Virginia University, Morgantown, WV, United States
raw_author_name: Inderjit Mehmi
raw_affiliation_strings: The Angeles Clinic and Research Institute, CS Cancer, Los Angeles, CA, United States
raw_author_name: Rachel Roberts-Thomson
raw_affiliation_strings: Medical Oncology, The Queen Elizabeth Hospital, Adelaide, SA, Australia
raw_author_name: James Strauss
raw_affiliation_strings: Mary Crowley Cancer Research, Dallas, TX, United States
raw_author_name: Sajeve Thomas
raw_affiliation_strings: Medical Oncology, Advent Health, Orlando, FL, United States
raw_author_name: Eric Whitman
raw_affiliation_strings: Oncology, Atlantic Health System, Morristown, NJ, United States
raw_author_name: Yan Xing
raw_affiliation_strings: Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, United States
raw_author_name: Meredith McKean
raw_affiliation_strings: Sarah Cannon Research Institute, Nashville, TN, United States
raw_author_name: Sabrina Collins
raw_affiliation_strings: Oncology Precision and Translational Medicine, Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA, United States
raw_author_name: Cheryl Li
raw_affiliation_strings: Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA, United States
raw_author_name: Gurpanna Saggu
raw_affiliation_strings: Precision and Translation Medicine, Oncology Therapeutic Area Unit, Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA, United States
raw_author_name: Tian Chen
raw_affiliation_strings: Oncology, Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA, United States
raw_author_name: Shining Wang
raw_affiliation_strings: Oncology Clinical Science, Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA, United States
raw_author_name: Marina Lewis
raw_affiliation_strings: Oncology, Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA, United States
raw_author_name: Xavier Parot
raw_affiliation_strings: Oncology Clinical Science, Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA, United States
raw_author_name: Melissa Johnson
raw_affiliation_strings: Sarah Cannon Research Institute, Nashville, TN, United States